Drug Type Probiotics |
Synonyms LACB-R + [1] |
Target- |
Action modulators |
Mechanism Bacteria replacements, Microbiome modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (30 Jun 2009), |
Regulation- |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Gastrointestinal Diseases | Japan | 30 Jun 2009 |





